Anthony L. Boral is Chief Medical Officer of Blueprint Medicines Corp. Currently has a direct ownership of 28,147 shares of BPMC, which is worth approximately $2.43 Million. The most recent transaction as insider was on Dec 14, 2020, when has been sold 10,000 shares (Common Stock) at a price of $117.8 per share, resulting in proceeds of $1,178,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
0% 12M change
Total Value Held $2.43 Million

Anthony L. Boral Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 14 2020
SELL
Open market or private sale
$1,178,000 $117.8 p/Share
10,000 Reduced 26.21%
28,147 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$150,100 $15.01 p/Share
10,000 Added 20.77%
38,147 Common Stock
Oct 23 2020
BUY
Exercise of conversion of derivative security
$109,370 $11.91 p/Share
9,183 Added 24.6%
28,147 Common Stock
ALB

Anthony L. Boral

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on BPMC

Follow Blueprint Medicines Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BPMC shares.

Notify only if

Insider Trading

Get notified when an Blueprint Medicines Corp insider buys or sells BPMC shares.

Notify only if

News

Receive news related to Blueprint Medicines Corp

Track Activities on BPMC